World's Best Scientists 2026 revealed!
Carol Dobson-Stone

Carol Dobson-Stone

D-Index & Metrics

Genetics

D-Index
41
Citations
7033
World Ranking
4329
National Ranking
144

Carol Dobson-Stone publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Carol Dobson-Stone sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 103 publications — 9th percentile

9% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Carol Dobson-Stone D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Carol Dobson-Stone sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 41 D-Index — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Carol Dobson-Stone is affiliated with the University of Sydney in Australia. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focus on neurology and molecular biology subfields, as well as physiology, cellular and molecular neuroscience, and genetics.

Their work centers on several key topics, including:

  • Amyotrophic Lateral Sclerosis Research
  • Alzheimer's disease research and treatments
  • Parkinson's Disease Mechanisms and Treatments
  • Genetic Neurodegenerative Diseases
  • Neurogenetic and Muscular Disorders Research
  • Neurological diseases and metabolism
  • Ubiquitin and proteasome pathways

Dobson-Stone has contributed to a number of peer-reviewed articles published in journals and venues such as bioRxiv (Cold Spring Harbor Laboratory), Alzheimer's & Dementia, Science Advances, Brain, and Biological Psychiatry. Repeated publication in these venues indicates a consistent focus on neurodegenerative and neurological disorders within their research output.

Recent papers authored or co-authored by Dobson-Stone include:

  • "Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing," 2022, Science Advances
  • "CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis," 2020, Brain
  • "Association of Variants in the SPTLC1 Gene With Juvenile Amyotrophic Lateral Sclerosis," 2021, JAMA Neurology
  • "Clinical and Biological Correlates of White Matter Hyperintensities in Patients With Behavioral-Variant Frontotemporal Dementia and Alzheimer Disease," 2021, Neurology
  • "Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood," 2022, Biological Psychiatry

Their collaborative network includes frequent co-authors such as John B. Kwok, Glenda M. Halliday, Olivier Piguet, Lauren Fitzpatrick, and Marianne Hallupp, reflecting multi-disciplinary collaborations within neurogenetics and neurology.

Overall, Dobson-Stone's research activities highlight a significant engagement with genetic and molecular aspects of neurodegenerative diseases, particularly amyotrophic lateral sclerosis and frontotemporal dementia. Their work integrates data across genetics, proteomics, and clinical neurology to understand disease mechanisms and potential therapeutic targets.

Best Publications

  • Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety

    J. M. Gatt;Charles Nemeroff;C. Dobson-Stone;C. Dobson-Stone;C. Dobson-Stone;R. H. Paul

  • Frontotemporal dementia and its subtypes: a genome-wide association study

    Raffaele Ferrari;Raffaele Ferrari;Dena G Hernandez;Dena G Hernandez;Michael A Nalls;Jonathan D Rohrer

  • Hailey–Hailey disease is caused by mutations in ATP2C1 encoding a novel Ca2+ pump

    Ralf Sudbrak;Joanna Brown;Carol Dobson-Stone;Simon Carter

  • A conserved sorting-associated protein is mutant in chorea-acanthocytosis

    Luca Rampoldi;Carol Dobson-Stone;Justin P. Rubio;Adrian Danek

  • Neuroinflammation in frontotemporal dementia.

    Fiona Bright;Eryn L. Werry;Carol Dobson-Stone;Carol Dobson-Stone;Olivier Piguet;Olivier Piguet

  • McLeod neuroacanthocytosis: genotype and phenotype.

    Adrian Danek;Justin P. Rubio;Luca Rampoldi;Mengfatt Ho

  • Analysis of the human VPS13 gene family.

    Antonio Velayos-Baeza;Andrea Vettori;Richard R. Copley;Carol Dobson-Stone

  • Methylation of the oxytocin receptor gene and oxytocin blood levels in the development of psychopathy

    Mark R. Dadds;Caroline Moul;Avril Cauchi;Carol Dobson-Stone

  • Severity of disease and risk of malignant change in hereditary multiple exostoses: A GENOTYPE-PHENOTYPE STUDY

    D. E. Porter;L. Lonie;M. Fraser;C. Dobson-Stone

  • Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.

    Agnes A. Luty;John B.J. Kwok;John B.J. Kwok;John B.J. Kwok;Carol Dobson-Stone;Carol Dobson-Stone;Carol Dobson-Stone;Clement T. Loy;Clement T. Loy;Clement T. Loy

  • CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia

    Kelly L. Williams;Kelly L. Williams;Simon Topp;Shu Yang;Bradley Smith

  • Chorein detection for the diagnosis of chorea-acanthocytosis

    Carol Dobson-Stone;Antonio Velayos-Baeza;Lea A Filippone;Sarah K Westbury

  • The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.

    D.M. Alexander;L.M. Williams;J.M. Gatt;C. Dobson-Stone;C. Dobson-Stone;C. Dobson-Stone

  • Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis.

    C Dobson-Stone;A Danek;L Rampoldi;RJ Hardie

  • The brain-derived neurotrophic factor Val66Met polymorphism predicts response to exposure therapy in posttraumatic stress disorder.

    Kim L. Felmingham;Kim L. Felmingham;Carol Dobson-Stone;Carol Dobson-Stone;Peter R. Schofield;Peter R. Schofield;Gregory J. Quirk

  • C9ORF72 repeat expansion in clinical and neuropathologic frontotemporal dementia cohorts.

    Carol Dobson-Stone;Marianne Hallupp;Lauren Bartley;Claire E. Shepherd

  • Disturbances in selective information processing associated with the BDNF Val66Met polymorphism: Evidence from cognition, the P300 and fronto-hippocampal systems

    Peter R. Schofield;Leanne M. Williams;Robert H. Paul;Justine M. Gatt

  • TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions

    Michael D. Gallagher;Eunran Suh;Murray Grossman;Lauren Elman

  • Neurologic phenotypes associated with acanthocytosis.

    R. H. Walker;H. H. Jung;C. Dobson-Stone;L. Rampoldi

  • COMT Val108/158Met polymorphism effects on emotional brain function and negativity bias

    Leanne M. Williams;Justine M. Gatt;Stuart M. Grieve;Carol Dobson-Stone

Frequent Co-Authors

John B.J. Kwok
John B.J. Kwok University of Sydney
Peter R. Schofield
Peter R. Schofield Neuroscience Research Australia
Glenda M. Halliday
Glenda M. Halliday University of Sydney
John R. Hodges
John R. Hodges University of Sydney
Olivier Piguet
Olivier Piguet University of Sydney
Anthony P. Monaco
Anthony P. Monaco Tufts University
Leanne M. Williams
Leanne M. Williams Stanford University
Evian Gordon
Evian Gordon University of Sydney
Richard A. Bryant
Richard A. Bryant University of New South Wales
Matthew C. Kiernan
Matthew C. Kiernan Royal Prince Alfred Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying genetics in the USA can open doors to a variety of rewarding career pathways in healthcare and research. Today, online education offers flexible options for advancing your career or transitioning into high-demand fields such as nursing and medical research.

If you’re interested in bridging genetics with clinical applications, consider online fnp programs to become a Family Nurse Practitioner (FNP). These programs are ideal for those seeking advanced practice roles that often intersect with genetic counseling and patient care.

There are also low cost nursing programs for students seeking affordable entry points into nursing careers, which may serve as a foundation for genetics-oriented roles.

For experienced nurses aiming for leadership or specialized positions, the best dnp programs online provide advanced education in evidence-based practice, often including coursework relevant to genetics and genomics.

Registered Nurses looking to enhance their credentials and knowledge can pursue the best online rn to bsn programs, which often explore the latest developments in healthcare, including genetics-driven patient care.

Best Scientists Citing Carol Dobson-Stone

Trending Scientists

Recently Published Articles